NEA Management Company, LLC

CIK

1512848

City

TIMONIUM

State / Country

MD

Stock

PHAT — Phathom Pharmaceuticals, Inc.

Top Portfolio Positions

25 positions · $1,745,893,804 total · as of Mar 31, 2026

Ticker	Company	Shares	Value (USD)	% of Portfolio	Open
ACLX	Arcellx, Inc. Healthcare	3,045,262	$349,656,982	20.03%
CELC	Celcuity Inc. Healthcare	2,285,561	$260,873,932	14.94%
SGP	SpyGlass Pharma, Inc. Healthcare	7,392,301	$191,534,518	10.97%
TRVI	Trevi Therapeutics, Inc. Healthcare	13,222,228	$157,741,180	9.03%
SVRA	Savara Inc Healthcare	24,471,264	$133,613,101	7.65%
GLUE	Monte Rosa Therapeutics, Inc. Healthcare	7,692,298	$126,538,302	7.25%
MBX	MBX Biosciences, Inc. Healthcare	3,614,486	$107,892,407	6.18%
ZBIO	Zenas BioPharma, Inc. Healthcare	4,023,219	$78,653,931	4.51%
COUR	Coursera, Inc. Consumer Defensive	12,867,769	$74,890,415	4.29%
AUPH	Aurinia Pharmaceuticals Inc. Healthcare	3,969,834	$58,832,939	3.37%

Portfolio Trend

25 quarters · across all stocks

Holdings in PHAT

Compact Export CSV

Shares Held

Position Value (USD)

12 quarters on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$21,777,477	1,960,169	0.0%	Shares	Defined	2026-05-15
2025-12-31	$32,519,203	1,960,169	0.0%	Shares	Defined	2026-02-17
2025-09-30	$23,071,189	1,960,169	0.0%	Shares	Defined	2025-11-14
2025-06-30	$18,798,020	1,960,169	0.0%	Shares	Defined	2025-08-14
2025-03-31	$12,290,259	1,960,169	0.0%	Shares	Defined	2025-05-14
2024-12-31	$15,916,572	1,960,169	0.0%	Shares	Defined	2025-02-14
2024-09-30	$35,439,855	1,960,169	0.0%	Shares	Defined	2024-11-14
2024-06-30	$20,189,740	1,960,169	0.0%	Shares	Defined	2024-08-14
2024-03-31	$20,816,994	1,960,169	0.0%	Shares	Defined	2024-05-15
2023-12-31	$17,896,342	1,960,169	+53.5%	Shares	Defined	2024-02-14
2023-09-30	$13,238,290	1,276,595	0.0%	Shares	Defined	2023-11-14
2023-06-30	$18,280,840	1,276,595	—	Shares	Defined	2023-08-11
No 13F history on record for this holder in this stock.